Direction Change Ahead, What to Expect - Research & Analysis on

Direction Change Ahead, What to Expect - Research & Analysis on
Gilead Sciences, Inc. and Idenix Pharmaceuticals, Inc. 
JAKARTA, INDONESIA -- (Marketwire) -- 11/13/12 --  Moments ago, introduced new coverage of Gilead Sciences, Inc.
(NASDAQ: GILD) and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX). Full
outlook, analysis and consensus opinion is available to readers via
the links below. 
The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include grim European forecasts with Germany's growth
prospects signaling potential trouble ahead, headlines of "fiscal
cliff" concerns with potential friction between Republicans and
Democrats regarding upcoming expiration of tax cuts and recent
effects of Hurricane Sandy still affecting major areas. When it comes
to discovering the right edge at the right time, all these factors
play into effect. For a deeper understanding of the mechanics behind
these events and how it can affect your portfolio, please refer to
our email newsletter delivered to your inbox. 
Traders Insight is releasing new coverage on Gilead Sciences, Inc.
for its current position within the health care sector. Gilead
Sciences, Inc. (Gilead) is a research-based biopharmaceutical company
that discovers, develops and commercializes medicines. Gilead's
primary areas of focus include human immunodeficiency virus
(HIV)/AIDS, liver diseases, such as hepatitis B and C and
cardiovascular/metabolic and respiratory conditions. A copy of this
report featuring Gilead Sciences, Inc. (NASDAQ: GILD) is available
Traders Insight has released research on Idenix Pharmaceuticals, Inc.
for its changing role within the consumer durables sector. Idenix
Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of human
viral diseases with operations in the United States and Europe. To
access the full research report on Idenix Pharmaceuticals, Inc.
(NASDAQ: IDIX) we welcome investors to visit: 
About Traders Insight
 Find direction and insight with Our model of enabling open collaboration between
members is breaking new ground into the investment community. By
tapping into the resources of the community, we are crowd-sourcing
our reach. As a result - we have been able to identify some of the
greatest moving companies on the market today. The evidence is in the
results, join today and experience what you've been missing. 
Cora S. Patton 
Press spacebar to pause and continue. Press esc to stop.